Magnetic Resonance Imaging (MRI) Assessment of Residual Breast Cancer After Neoadjuvant Chemotherapy: Relevance to Tumor Subtypes and MRI Interpretation Threshold.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Works matching AU Lee, Keun Seok
Results: 80
1
2
Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
3
Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association With Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
4
Effects of Second and Subsequent Lines of Chemotherapy for Metastatic Breast Cancer*.
- Published in:
- Clinical Breast Cancer, 2015, v. 15, n. 1, p. e55, doi. 10.1016/j.clbc.2014.09.001
- By:
- Publication type:
- Article
5
The invasive lobular carcinoma as a prototype luminal A breast cancer: A retrospective cohort study.
- Published in:
- BMC Cancer, 2010, v. 10, p. 664, doi. 10.1186/1471-2407-10-664
- By:
- Publication type:
- Article
6
Potential antitumor effects of nitrogen-containing bisphosphonate in hormone receptor negative breast cancer patients with bone metastases.
- Published in:
- BMC Cancer, 2009, v. 9, p. 1, doi. 10.1186/1471-2407-9-154
- By:
- Publication type:
- Article
7
Social support and depressive mood 1 year after diagnosis of breast cancer compared with the general female population: a prospective cohort study.
- Published in:
- 2011
- By:
- Publication type:
- journal article
8
Association of Polymorphisms and Haplotypes in the Insulin-Like Growth Factor 1 Receptor (IGF1R) Gene with the Risk of Breast Cancer in Korean Women.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0084532
- By:
- Publication type:
- Article
9
Correlation of HER2, p95HER2 and HER3 Expression and Treatment Outcome of Lapatinib plus Capecitabine in her2-Positive Metastatic Breast Cancer.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0039943
- By:
- Publication type:
- Article
10
Incidence and Predictors of Febrile Neutropenia among Early-Stage Breast Cancer Patients Receiving Anthracycline-Based Chemotherapy in Korea.
- Published in:
- Oncology, 2016, v. 91, n. 5, p. 274, doi. 10.1159/000449226
- By:
- Publication type:
- Article
11
Progranulin and Breast Cancer Mortality: 13-Year Follow-Up of a Cohort Study.
- Published in:
- Breast Cancer: Targets & Therapy, 2023, v. 15, p. 251, doi. 10.2147/BCTT.S406685
- By:
- Publication type:
- Article
12
Changes in health-related quality of life and quality of care among terminally ill cancer patients and survival prediction: Multicenter prospective cohort study.
- Published in:
- Palliative & Supportive Care, 2015, v. 13, n. 4, p. 1103, doi. 10.1017/S1478951514000960
- By:
- Publication type:
- Article
13
Genome‐wide association study of genetic variants related to anthracycline‐induced cardiotoxicity in early breast cancer.
- Published in:
- Cancer Science, 2020, v. 111, n. 7, p. 2579, doi. 10.1111/cas.14446
- By:
- Publication type:
- Article
14
A phase II trial of the pan‐HER inhibitor poziotinib, in patients with HER2‐positive metastatic breast cancer who had received at least two prior HER2‐directed regimens: results of the NOV120101‐203 trial.
- Published in:
- International Journal of Cancer, 2018, v. 143, n. 12, p. 3240, doi. 10.1002/ijc.31651
- By:
- Publication type:
- Article
15
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15).
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359231225029
- By:
- Publication type:
- Article
16
Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211061989
- By:
- Publication type:
- Article
17
Correction: ASO Author Reflections: Assessing the Efficacy of Multimodal Sentinel Lymph Node Mapping in Breast Cancer Patients After Neoadjuvant Chemotherapy.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
18
ASO Author Reflections: Assessing the Efficacy of Multimodal Sentinel Lymph Node Mapping in Breast Cancer Patients After Neoadjuvant Chemotherapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 10, p. 6841, doi. 10.1245/s10434-024-15580-7
- By:
- Publication type:
- Article
19
ASO Visual Abstract: Clinical Application of Multimodal Sentinel Lymph Node Mapping Method in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: An Interim Analysis.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
20
Clinical Application of Multimodal Sentinel Lymph Node Mapping Method in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: An Interim Analysis.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 8, p. 5141, doi. 10.1245/s10434-024-15317-6
- By:
- Publication type:
- Article
21
The Sentinel Lymph Node Biopsy Using Indocyanine Green Fluorescence Plus Radioisotope Method Compared With the Radioisotope-Only Method for Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prospective, Randomized, Open-Label, Single-Center Phase 2 Trial
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 8, p. 2409, doi. 10.1245/s10434-019-07400-0
- By:
- Publication type:
- Article
22
CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0182107
- By:
- Publication type:
- Article
23
Correction to: The impact of caregiver's role preference on decisional conflicts and psychiatric distresses in decision making to help caregiver's disclosure of terminal disease status.
- Published in:
- 2019
- By:
- Publication type:
- corrected article
24
The impact of caregiver's role preference on decisional conflicts and psychiatric distresses in decision making to help caregiver's disclosure of terminal disease status.
- Published in:
- 2018
- By:
- Publication type:
- journal article
25
Mutation analysis using cell-free DNA for endocrine therapy in patients with HR+ metastatic breast cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-84999-9
- By:
- Publication type:
- Article
26
Criteria for identifying residual tumours after neoadjuvant chemotherapy of breast cancers: a magnetic resonance imaging study.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-020-79743-8
- By:
- Publication type:
- Article
27
Percutaneous Radiofrequency Ablation for Liver Metastases in Breast Cancer Patients.
- Published in:
- Breast Journal, 2013, v. 19, n. 5, p. 563, doi. 10.1111/tbj.12170
- By:
- Publication type:
- Article
28
Neoadjuvant Chemotherapy with Concurrent Letrozole for Estrogen Receptor-Positive and HER2-Negative Breast Cancer: An Open-Label, Single-Center, Nonrandomized Phase II Study (NeoCHAI).
- Published in:
- Cancers, 2024, v. 16, n. 18, p. 3122, doi. 10.3390/cancers16183122
- By:
- Publication type:
- Article
29
Clinicopathological Factors Associated with Oncotype DX Risk Group in Patients with ER+/HER2- Breast Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 18, p. 4451, doi. 10.3390/cancers15184451
- By:
- Publication type:
- Article
30
Risk Factors for Palbociclib-Induced Early Developing Neutropenia in Patients with Hormone Receptor-Positive Metastatic Breast Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 10, p. 2810, doi. 10.3390/cancers15102810
- By:
- Publication type:
- Article
31
Integrative In Vivo Drug Testing Using Gene Expression Signature and Patient-Derived Xenografts from Treatment-Refractory HER2 Positive and Triple-Negative Subtypes of Breast Cancer.
- Published in:
- Cancers, 2019, v. 11, n. 4, p. 574, doi. 10.3390/cancers11040574
- By:
- Publication type:
- Article
32
Phase I and pharmacokinetic study of the vascular-disrupting agent CKD-516 (NOV120401) in patients with refractory solid tumors.
- Published in:
- Pharmacology Research & Perspectives, 2020, v. 8, n. 2, p. 1, doi. 10.1002/prp2.568
- By:
- Publication type:
- Article
33
Long-Term Safety and Effectiveness of PF-05280014 (a Trastuzumab Biosimilar) Treatment in Patients with HER2-Positive Metastatic Breast Cancer: Updated Results of a Randomized, Double-Blind Study.
- Published in:
- BioDrugs, 2022, v. 36, n. 1, p. 55, doi. 10.1007/s40259-021-00513-7
- By:
- Publication type:
- Article
34
Final results of the randomized phase 2 LEO trial and bone protective effects of everolimus for premenopausal hormone receptor‐positive, HER2‐negative metastatic breast cancer.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 4, p. 917, doi. 10.1002/ijc.33613
- By:
- Publication type:
- Article
35
Molecular alterations and poziotinib efficacy, a pan‐HER inhibitor, in human epidermal growth factor receptor 2 (HER2)‐positive breast cancers: Combined exploratory biomarker analysis from a phase II clinical trial of poziotinib for refractory HER2‐positive breast cancer patients
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 6, p. 1669, doi. 10.1002/ijc.32188
- By:
- Publication type:
- Article
36
Exploratory biomarker analysis from a phase II clinical trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine for HER2-negative metastatic breast cancer patients (KCSG BR13-11).
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 367, doi. 10.1007/s10549-019-05400-y
- By:
- Publication type:
- Article
37
Prognostic impact of skeletal muscle volume derived from cross-sectional computed tomography images in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 172, n. 2, p. 425, doi. 10.1007/s10549-018-4915-7
- By:
- Publication type:
- Article
38
Use of adjuvant chemotherapy in hormone receptor-positive breast cancer patients with or without the 21-gene expression assay.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 170, n. 1, p. 69, doi. 10.1007/s10549-018-4740-z
- By:
- Publication type:
- Article
39
Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2008, v. 108, n. 2, p. 241, doi. 10.1007/s10549-007-9591-y
- By:
- Publication type:
- Article
40
Stage-to-stage Comparison of Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Pathological Lymph Node Positive Breast Cancer Patients.
- Published in:
- Japanese Journal of Clinical Oncology, 2012, v. 42, n. 11, p. 995, doi. 10.1093/jjco/hys130
- By:
- Publication type:
- Article
41
Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211061989
- By:
- Publication type:
- Article
42
Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study.
- Published in:
- Breast Cancer Research, 2011, v. 13, n. 1, p. 1, doi. 10.1186/bcr2856
- By:
- Publication type:
- Article
43
Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study.
- Published in:
- 2011
- By:
- Publication type:
- journal article
44
The Significance of Serum HER2 Levels at Diagnosis on Intrinsic Subtype-Specific Outcome of Operable Breast Cancer Patients.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0163370
- By:
- Publication type:
- Article
45
Quality of life on TSU-68: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2017, v. 13, n. 6, p. 365, doi. 10.1111/ajco.12681
- By:
- Publication type:
- Article
46
Accumulation of p53 determined by immunohistochemistry as a prognostic marker in node negative breast cancer; analysis according to st gallen consensus and intrinsic subtypes.
- Published in:
- Journal of Surgical Oncology, 2011, v. 103, n. 3, p. 207, doi. 10.1002/jso.21819
- By:
- Publication type:
- Article
47
Contribution of tumour and immune cells to PD‐L1 expression as a predictive biomarker in metastatic triple‐negative breast cancer: exploratory analysis from KEYNOTE‐119.
- Published in:
- Journal of Pathology: Clinical Research, 2024, v. 10, n. 3, p. 1, doi. 10.1002/2056-4538.12371
- By:
- Publication type:
- Article
48
Anti-tumor activity of BET inhibitors in androgen-receptor-expressing triple-negative breast cancer.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-49366-9
- By:
- Publication type:
- Article
49
Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1.
- Published in:
- 2017
- By:
- Publication type:
- journal article
50
Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16).
- Published in:
- 2019
- By:
- Publication type:
- journal article